Chan-Mo Yang

Prof. Chan-Mo Yang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2024
Verified
Conference Paper
Open access
TKTaewan Kim
Taewan Kim
SBSeolyeong Bae
Seolyeong Bae
HKHyun Ah Kim
Hyun Ah Kim
SLSu-Woo Lee
Su-Woo Lee
HHHwajung Hong
Hwajung Hong
YKYoung-Ho Kim
Young-Ho Kim
Large Language Models (LLMs) offer promising opportunities in mental health domains, although their inherent complexity and low controllability elicit concern regarding their applicability in clinical settings. We present MindfulDiary, an LLM-driven journaling app that helps psychiatric patients document daily experiences through conversation. Designed in collaboration with mental health professionals, MindfulDiary takes a state-based approach to safely comply with the experts’ guidelines while carrying on free-form conversations. Through a four-week field study involving 28 patients with major depressive disorder and five psychiatrists, we examined how MindfulDiary facilitates patients’ journaling practice and clinical care. The study revealed that MindfulDiary supported patients in consistently enriching their daily records and helped clinicians better empathize with their patients through an understanding of their thoughts and daily contexts. Drawing on these findings, we discuss the implications of leveraging LLMs in the mental health domain, bridging the technical feasibility and their integration into clinical settings.


30 November 2022 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
JLJae Seok Lim
Jae Seok Lim
CYChan-Mo Yang
Chan-Mo Yang
JBJu-Won Baek
Ju-Won Baek
SLSang-Yeol Lee
Sang-Yeol Lee
BKBung-Nyun Kim
Bung-Nyun Kim
Jae Seok Lim, Chan-Mo Yang, Ju-Won Baek, Sang-Yeol Lee, Bung-Nyun Kim. Clin Psychopharmacol Neurosci 2022;20:609-20. https://doi.org/10.9758/cpn.2022.20.4.609

22 May 2023 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
CYChan-Mo Yang
Chan-Mo Yang
JSJaeyoung Shin
Jaeyoung Shin
JKJohanna Inhyang Kim
Johanna Inhyang Kim
YLYou Bin Lim
You Bin Lim
SPSo Hyun Park
So Hyun Park
BKBung-Nyun Kim
Bung-Nyun Kim
Chan-Mo Yang, Jaeyoung Shin, Johanna Inhyang Kim, You Bin Lim, So Hyun Park, Bung-Nyun Kim. Clin Psychopharmacol Neurosci 2023;21:693-700. https://doi.org/10.9758/cpn.22.1025

25 April 2021 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
KHKyu-Sic Hwang
Kyu-Sic Hwang
HCHye Ji Choi
Hye Ji Choi
CYChan-Mo Yang
Chan-Mo Yang
JHJeongwan Hong
Jeongwan Hong
HLHye-Jin Lee
Hye-Jin Lee
SLSang-Yeol Lee
Sang-Yeol Lee
Objective Coronavirus disease 2019 (COVID-19) has psychological effects such as anxiety and depression as well as direct infection in people. The Fear of COVID-19 scale is a scale that can measure anxiety related to COVID-19 in a short time. The purpose of this study was to verify the reliability and validity the Korean version of Fear of COVID-19 scale (KF-COVID-19S).Methods The data of total 186 normal adults and 17 patients were finally used for the statistical analysis. For internal consistency, Cronbach’s α was calculated. For concurrent and discriminant validity, the correlations with the Hospital Anxiety and Depression scale (HADS), Patient Health Questionnaire-15 (PHQ-15), World Health Organization Quality of Life Assessment Instrument Brief Form (WHOQOLBREF) were analyzed. For construct validity, exploratory and confirmatory factor analysis were conducted.Results Cronbach alpha was 0.88. The two-factor model (factor 1: Physical fear, factor 2: Emotional fear) showed significantly positive correlations and appeared to be “good” fitness (CFI=0.906, IFI=0.907, NFI=0.902).Conclusion The KF-COVID-19S can be a useful scale that can measure the physical and emotional fears associated with COVID-19 in a short time. Because the psychiatric patients are a more vulnerable group to the fear, it is thought that the KF-COVID-19S will help to determine the patient’s level of anxiety and make a therapeutic plan for the underlying mental disorder.

25 February 2022 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
HCHye Ji Choi
Hye Ji Choi
CYChan-Mo Yang
Chan-Mo Yang
SLSang-Yeol Lee
Sang-Yeol Lee
HLHye-Jin Lee
Hye-Jin Lee
SJSeungHo Jang
SeungHo Jang
Objective The aim of this study was to assess the psychosocial characteristics of the employees working at a university hospital and investigated the factors affecting their quality of life (QOL) under COVID-19.Methods This study enrolled 1,191 healthcare workers from a university hospital, including doctors, nurses, administrative officer and technicians. Besides demographic information, depression, anxiety, somatization, insomnia, resilience, and QOL were assessed.Results The nurses presented significantly higher scores for anxiety, depression and showed significantly higher insomnia scores and significantly lower resilience scores. The occupations showed significant differences in the QOL and sub-groups, including the overall quality of life and general health (F=4.774, p<0.001), psychological domain (F=6.230, p<0.001), and environment domain (F=5.254, p<0.001). There was a positive correlation between the QOL and resilience (r=0.608, p<0.01). However, depression (r=-0.502, p<0.01), anxiety (r=-0.425, p<0.01), somatization (r=-0.364, p<0.01), and insomnia (r=-0.385, p<0.01) showed negative correlations with the QOL. Resilience was the most important factor influencing the QOL.Conclusion The results of this study showed that low resilience adversely affected the QOL and the mental health of the healthcare workers, which consequently had a direct effect on the quality of medical care given to patients.